Dean Ruether
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 4
- Renal cell carcinoma treatment 3
- Oncology 6
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Srikala S. Sridhar (4 shared papers)Jingsong Zhang (1 shared paper)Amal Melhem‐Bertrandt (2 shared papers)Sandy Srinivas (1 shared paper)Peter M. Venner (2 shared papers)Joshua Michael Lang (2 shared papers)Thomas W. Flaig (1 shared paper)David C. Smith (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Clinical Genitourinary Cancer (2 papers)JCO Oncology Practice (2 papers)BMJ Open (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Dean Ruether
30 papers receiving 808 citations
Dean Ruether's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 205
- Pulmonary and Respiratory Medicine 235
- Surgery 230
- Cancer Research 72
- Hematology 42
Countries citing papers authored by Dean Ruether
This map shows the geographic impact of Dean Ruether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Ruether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Ruether more than expected).
Fields of papers citing papers by Dean Ruether
This network shows the impact of papers produced by Dean Ruether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Ruether. The network helps show where Dean Ruether may publish in the future.
Co-authors
The 25 scholars most cited alongside Dean Ruether, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 276 |
| 2 | 2011 | 213 | |
| 3 | 2021 | 35 | |
| 4 | 2013 | 32 | |
| 5 | 2021 | 28 | |
| 6 | 2004 | 27 | |
| 7 | 1997 | 26 | |
| 8 | 2012 | 26 | |
| 9 | 2013 | 18 | |
| 10 | 2017 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2017 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2008 | 10 | |
| 16 | 2017 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2016 | 9 | |
| 19 | 2018 | 7 | |
| 20 | 2016 | 5 |
About Dean Ruether
Dean Ruether is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Hematology, having authored 32 papers that have together received 829 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Renal cell carcinoma treatment (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Renal and related cancers (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Oncology (205 citations), Pulmonary and Respiratory Medicine (235 citations), Surgery (230 citations), Cancer Research (72 citations) and Hematology (42 citations). Dean Ruether has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Srikala S. Sridhar, Jingsong Zhang, Amal Melhem‐Bertrandt, Sandy Srinivas, Peter M. Venner, Joshua Michael Lang, Thomas W. Flaig, David C. Smith, Daniel Peter Petrylak and Joaquina Celebre Baranda. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Genitourinary Cancer, JCO Oncology Practice and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.